NCT06528444

Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

Randomized, Double-blind, Multicenter, Phase III Clinical Trial Evaluating the Efficacy and Safety of Dexamethasone Compared to Placebo in Patients With Severe Influenza

• Status: Recruiting
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 42 (estimated)
• Sponsor: Instituto de Investigación Sanitaria y Biomédica de Alicante · Network
• Sex: All
• Age: 18 Years – 100 Years
• Healthy volunteers: Accepted

Summary

Clinical trial with an active ingredient of a pharmaceutical specialty marketed in Spain vs. placebo. Randomized, double-blind, multicenter phase III clinical trial that evaluates the efficacy and safety of dexamethasone compared to placebo in patients with severe influenza.

Conditions

• Influenza

Interventions

Type	Name	Description
DRUG	Grup 1 placebo	placebo 1 capsule (6 mg) /day for 7 days.
DRUG	Grup 2 dexametasona	dexamethasone 1 capsule (6 mg)/day for 7 days

Timeline

• Start date: 2024-10-01
• Primary completion: 2028-10-31
• Completion: 2028-10-31
• First posted: 2024-07-30
• Last updated: 2025-02-19

Locations

2 sites across 1 country: Spain